stars 1 stars 2 stars 3

Norma Hellas S.A. is the marketing authorization holder of more than 70 pharmaceutical products and launches more than 46 of them. New products are under approval through national as well as mutual and decentralized procedures. Moreover new products and advanced pharmaceutical forms are under development in research centers in Greece and Europe. The company’s main business segment is the health care products, which are available in the Greek market as well as East Europe, Middle East and Central Asia. The aim of the company is the development and trading of pharmaceutical products, with a strong position in branded generics area. Our commitment is the protection of public health and the improvement of the human’s life quality.

Norma Hellas s.a Questions

The Norma Hellas s.a annual revenue was $2 million in 2026.

Georgios Tsalikis is the Vice President of Norma Hellas s.a.

6 people are employed at Norma Hellas s.a.

Norma Hellas s.a is based in Athens, Attica.

The NAICS codes for Norma Hellas s.a are [522, 52, 5222].

The SIC codes for Norma Hellas s.a are [611, 61].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users